| 000 | 02468 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250513214210.0 | ||
| 264 | 0 | _c20000825 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(00)00265-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDinter, H | |
| 245 | 0 | 0 |
_aThe type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cAug 2000 |
||
| 300 |
_a136-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 4 |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
| 650 | 0 | 4 |
_aInterleukin-5 _xbiosynthesis |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aOxazoles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Lew |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSpleen _xdrug effects |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTh1 Cells _xcytology |
| 650 | 0 | 4 |
_aTh2 Cells _xcytology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aTse, J | |
| 700 | 1 | _aHalks-Miller, M | |
| 700 | 1 | _aAsarnow, D | |
| 700 | 1 | _aOnuffer, J | |
| 700 | 1 | _aFaulds, D | |
| 700 | 1 | _aMitrovic, B | |
| 700 | 1 | _aKirsch, G | |
| 700 | 1 | _aLaurent, H | |
| 700 | 1 | _aEsperling, P | |
| 700 | 1 | _aSeidelmann, D | |
| 700 | 1 | _aOttow, E | |
| 700 | 1 | _aSchneider, H | |
| 700 | 1 | _aTuohy, V K | |
| 700 | 1 | _aWachtel, H | |
| 700 | 1 | _aPerez, H D | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 108 _gno. 1-2 _gp. 136-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(00)00265-4 _zAvailable from publisher's website |
| 999 |
_c10850643 _d10850643 |
||